In recent years, globalization is developing in a deeper and broader direction. Personnel exchanges around the world have become closer, regional economic dependence has become closer, and international tourism and business activities have become more frequent. The accelerating globalization has accelerated global economic integration, industrialization, urbanization and global warming. These complex environmental changes also make the world full of various public health risks. In 2020, COVID-19 had a major impact on the global economy, society and other fields.
Countries around the world have been tested in response to this epidemic, and their public health systems and medical systems are different. However, through this epidemic, countries also pay more attention to the construction of public health system, the development of life technology and the development of biomedical industry.
Looking forward to the new year, we sorted out the top ten medical hotspots in the world in the future.
1,Countries all over the world are competing to develop new vaccines, or lead to new vaccine wars
At the end of 2020, many new crown vaccines were approved in many countries and regions in the world. Pharmaceutical enterprises quickly promoted the research and development of relevant vaccines in a short time and carried out multiple clinical studies at the same time. At the same time, Britain, Russia and other countries have taken the lead in vaccinating the people, and France, Germany, Romania, Portugal, Spain, Japan and other countries have also announced the new crown vaccination plan.
However, in view of the limited number of vaccines that have been produced and marketed, we first face the problem of how to distribute them. In addition to developed countries, whether some countries or regions with relatively backward economic strength will also get more equal vaccination opportunities will become a new social issue. According to Agence France Presse, on January 14, Hans Kluge, who regional director for Europe, said at a press conference that at present, 95% of the doses of coronal disease vaccine used in the world are limited to 10 countries, calling for a more equitable distribution of vaccines.
2,The number of depression patients and suicides in the world has increased sharply, and mental health has attracted attention again
The novel coronavirus pneumonia not only causes the loss of precious lives of tens of millions of people worldwide, but also causes a large number of enterprises to go bankrupt, and the number of unemployed people in different regions of the world has increased sharply. People have more worries and worries about the future. The impact of the epidemic on mental health should not be underestimated. In 2020, due to the impact of the epidemic, women accounted for the majority of the people who chose to commit suicide. According to the data of the Japanese police agency, the number of suicides in Japan in October and November 2020 was about 2200 and 1800 respectively. The number of suicides from January to November 2020 was more than 19000. Among them, the number of suicides in October increased by about 83% for women and 22% for men compared with the same month last year.
According to WHO statistics, the incidence rate of global depression is about 11%, and about 350 million of the world’s depressed patients. At present, depression has become the main killer of mankind in the 21st century. 15% of serious patients will choose suicide to end their lives. 2 / 3 of patients have had the idea of suicide. The number of suicides due to depression is estimated to be as high as 1 million every year.
There are two main aspects of mental health problems, loneliness and social isolation. Facing these people with mental health problems, the whole society, especially the relatives and friends around them, should give more understanding and support. It is particularly important for society to popularize science and prevent mental diseases. Early prevention and early intervention can avoid more tragedies.
3,Telemedicine and Internet medicine will continue to develop
Since the outbreak of novel coronavirus pneumonia, telemedicine and Internet health care have attracted much attention. Apart from many internet medical companies using technology and mode innovation, launching light inquiring and health consultation services, many public hospitals have also made full use of telemedicine and internet medical platforms, strengthening remote consultation and consultation services. To some extent, it has played a good role in reducing the risk of cross infection caused by patients going to the hospital, and indirectly realized patient diversion, follow-up of common diseases and mild disease screening. Telemedicine has achieved rapid development under the epidemic situation in 2003 and 2020.
In addition, many elderly people with basic diseases choose to stay at home. At the time of covid-19 pandemic, telemedicine and Internet medicine enable patients to safely obtain remote consultation and other services at home. Japan and other countries also recognized the possibility of “first diagnosis” of online consultation for the first time.
At present, telemedicine has become a key part of the health care system, but telemedicine itself can not solve the actual treatment problem. Although many patients are reluctant to go to medical institutions during the epidemic, and a considerable number of people choose online health consultation, most people prefer the combination of face-to-face treatment and telemedicine.
With the continuous development of Internet technology and people’s diversified needs for medical treatment, it is believed that more and more enterprises will enter the field of internet medical treatment.
4,The global shortage of medical staff has attracted attention, and the training of medical staff will become an important direction in the future
The 2020 global nursing status report released by the World Health Organization (who) on “World Health Day” on April 7, 2020 shows that there is a huge gap of 5.9 million nurses in the world. In addition to nurses, there has always been a gap in medical personnel in many countries. Who says nurses account for more than half of the world’s health workers and provide vital services to the health system. Who issued an urgent appeal to encourage countries to train more professional medical talents.
The report points out that the number of nurses worldwide is 27.9 million, including 19.3 million professional nurses. In 2018, the global nurse gap reached 5.9 million, and the distribution is uneven. Countries accounting for half of the world’s population have 80% of the world’s nurses. The nurse gap is particularly serious in low-income countries such as Africa, Southeast Asia and Latin America. The problems of medical staff in developed countries are mainly the older age structure of the working group, excessive dependence on international recruitment, insufficient supply capacity and so on. According to the world nursing report 2020 of who, if no action is taken, the global nurse shortage will reach 4.6 million by 2030. Dr. Ge Xijian, who regional director for the Western Pacific, pointed out that countries “should increase investment in nursing teams, and this problem has become unprecedented. Regardless of day and night, nurses are struggling to fight the frontier of the new crown virus, and they will save lives and protect the public all day and night. Governments of countries in the Western Pacific region must increase their investment in nursing teams as one of the basic contents of preparation for meeting health challenges, not only to meet health challenges such as emerging infectious diseases, but also to meet health challenges brought about by climate change, population aging and the increasing number of non communicable diseases. ”
5,The field of biomedicine will usher in a new round of development opportunities
In recent years, with the continuous change of disease spectrum and the rapid development of life science and biotechnology, the global biomedical industry has also entered the stage of accelerated development. Biomedical industry is composed of biotechnology industry and pharmaceutical industry. Biological medicine refers to a kind of products for prevention, treatment and diagnosis made by comprehensively using the scientific principles and methods of Microbiology, chemistry, biochemistry, biotechnology and pharmacy. Compared with chemical drugs, biological drugs have higher safety and effectiveness, less side effects and toxicity, so they have attracted much attention and are also the main object of capital pursuit.
According to the report on in-depth analysis and development planning consulting suggestions of China’s biomedical industrial parks from 2017 to 2021, at present, the global biomedical industry presents a trend of agglomeration development, mainly distributed in the United States, Europe, Japan, India, Singapore, China and other countries and regions. Among them, the United States, Europe, Japan and other developed countries and regions dominate. Bio pharmaceutical has been widely used in the treatment of cancer, diabetes and chronic diseases. The biomedical industry in Europe has a good industrial foundation and technical advantages, which also makes the biomedical industry in the forefront of the world. Although Japan, an Asian country, started its development in the field of biomedicine later than Europe and the United States, it developed very rapidly and became a leader in Asia. In addition to Japan, the biomedical industry in Asian countries such as China, India and Singapore has also developed rapidly. Asia has become another biomedical center in the global biomedical industry except North America and Europe.
6,Chronic disease management promotes the rapid growth of the home medical market, and there is a strong demand for home medical devices and wearable devices
In recent years, with the continuous development of health management industry, there is an increasing demand for home medical devices and wearable devices that can help patients diagnose various chronic diseases. The value of the home healthcare market is expected to reach US $25.734 million by 2021, with a growth rate of 8.6% from 2016 to 2021. With the development of population aging, people pay more attention to the health management of themselves and family members, and the market demand is becoming stronger and stronger. The household medical equipment industry has attracted the attention of the capital market and officially entered the golden development period.
Portable devices include blood glucose monitoring, pregnancy detection kit, HIV detection kit and heart rate monitoring system. Patients can be tested at home, with the advantages of simple operation, compact size and convenient portability. With the acceleration of population aging, the increase of population with chronic diseases, the rapid development of technology and the introduction of relevant government support policies, the family medical market is expected to grow significantly. Especially with the increase of the elderly population, people’s health awareness and the demand for physical examination have played a boosting role.
At the same time, technological progress has also stimulated the development of home nursing equipment and nursing services. The substantial increase in demand for mobile products (such as walkers, cranes, crutches, wheelchairs and mobile Scooters) is also an important factor driving the growth of the family medical market. In order to meet the growing needs of customers, it is also a general trend for companies providing home medical equipment to expand and launch new types of home medical equipment through cooperation.
Influenced by COVID-19, the demand for medical masks, medical protective products, nucleic acid detection boxes and ECMO has surged, and some medical devices and products have been out of stock. Various health care departments and other relevant departments have issued emergency policies, such as speeding up the examination and approval, strengthening supervision, and ensuring the safety of medical devices.
7,Artificial intelligence (AI) is changing the future medical treatment. North America, Asia and Europe have become the regions with the fastest development of artificial intelligence in the world
In recent years, with the rapid progress of science and technology, the development tide of artificial intelligence (AI) and ICT has gradually poured into the medical field. Both community medical care and advanced medical care are undergoing earth shaking changes. Artificial intelligence (AI), as a high-tech leading the future life, the continuous integration of the new generation of artificial intelligence and the health care industry has injected new kinetic energy into economic and social development and is profoundly changing people’s production and life style. By 2021, the global artificial intelligence market will reach US $2.1 trillion. In the coming future · global AI innovation integration application cities and Prospects (hereinafter referred to as the report) released by Deloitte, it is pointed out that “we predict that the scale of the world artificial intelligence market will exceed US $6 trillion in 2025”. It is expected that the global artificial intelligence market will continue to maintain rapid growth in the next few years, and the global market will reach US $15.7 trillion by 2030, About 104 trillion yuan. The algorithm of artificial intelligence can mine medical records faster and design the best treatment scheme for patients. It has highlighted its advantages over artificial intelligence in some fields such as film reading. Google’s DeepMind showed an average of 11.5% in detecting breast cancer based on molecular data. In addition, artificial intelligence will play a greater role in the field of new drug research and development, helping people find disruptive technologies in the healthcare industry.
In recent years, artificial intelligence has made great progress in North America, Asia and Europe. With the outbreak of market demand and the increase of investment, North America, Asia and Europe are the regions with the fastest development of artificial intelligence in the world. At present, artificial intelligence has been applied in the fields of colorectal cancer, gastric cancer, breast cancer, skin cancer, cerebral aneurysm, Alzheimer’s disease, and other fields to assist doctors in making more efficient and accurate diagnosis, especially in image analysis and diagnosis, pathological reading and so on.
8,The scale of the global rehabilitation medical market accelerated, and the rehabilitation robot market increased to US $3.2 billion
Rehabilitation is an important part of the trinity of “prevention, clinical treatment and rehabilitation”. It is mainly divided into three stages: acute rehabilitation, post acute rehabilitation and long-term care. With the continuous development of population aging, the demand for rehabilitation medicine is expanding. Due to the differences of economic level and medical level in different regions, there are also some problems such as the shortage of rehabilitation professionals while the development of rehabilitation medicine is accelerating. In addition, in order to better alleviate the shortage of nurses and reduce the business load of nurses, the expectation of medical and rehabilitation robots has become higher and higher in recent years. There is a certain gap between developing countries and developed countries such as the United States and Japan in the supply of rehabilitation medical talents, public awareness of rehabilitation and the total amount of rehabilitation resources.
Rehabilitation robot is an important branch of medical robot. Its research includes many fields, such as rehabilitation medicine, biomechanics, mechanics, computer science, materials science and so on. In the field of rehabilitation robots, Japan, which first entered the aging society, has a relatively leading technical advantage in the world. In 2019, the global medical robots were mainly surgical support robots, and then the robot market in rehabilitation and nursing support expanded rapidly. Since 2020, the “Nursing Robot” that assists the self-reliance support of the elderly and reduces the burden of practitioners has developed rapidly. It is relatively mature to assist the elderly in moving between bed and wheelchair, daily rehabilitation training, bathing, sensors for cognitive patients, etc. through nursing robots. According to the prediction of Grandview research, the market share of exoskeleton robots and assisted rehabilitation robots will increase significantly from 2012 to 2022. It is estimated that the compound annual growth rate of generalized rehabilitation robots in the next five years will be about 37%, of which the compound annual growth rate of rehabilitation robots is 21% and that of exoskeleton robots is 47%, which is much higher than the average growth rate of other types of medical robots.
With the deepening of the combination of medicine and engineering, technologies developed in other fields such as clinical and engineering are more and more used in rehabilitation treatment. For example, in the rehabilitation treatment to restore the function of the arm and finger, the “function evaluation” of how far the patient can move the arm and finger is an important indicator.
9,Global capital overweight medical and health investment and financing, with biomedical financing ranking first
In 2020, the total amount of global medical and health financing reached a record high, with a year-on-year increase of 41%; In the whole year, there were 205 financing transactions of more than US $100 million, accounting for 9%. Among them, the global financing amount of biomedicine ranks first, exceeding the sum of digital health and devices. OrbiMed is the most active organization in investing in global health care, with a record breaking total of 50 shots in the whole year, mainly in the field of biomedicine. Biopharmaceuticals have the advantages of less side effects and high therapeutic effect. On January 7, 2021, Fujifilm (Tokyo) announced the establishment of a new manufacturing base for biomedical products in the United States, with an investment of more than 200 billion yen. In 2020, investment and financing mainly focused on telemedicine, in vitro diagnosis, home care, vaccine research and development and other fields. The proportion of investment in biomedicine and medical materials will increase in 2021. In addition, neurodegenerative diseases have become the focus, and financing projects have focused on the field of small molecule drugs.
10,Electronic health record (EHR) has attracted more and more attention and is expected to be further standardized and cloud based
Because of the global spread in COVID-19, the sharing of medical data around the world has become particularly important. Information sharing in the field of health and public health can help promote innovation and pave the way for interoperability and standardization of electronic health records. Electronic health record (EHR) is a digital record centered on personal health, health care and treatment. It is an individualized digital health record. Electronic health records can span different medical institutions and systems, and realize the exchange and sharing of medical information between different information providers and users. It will help to improve patients’ medical safety, improve medical quality, improve health care, promote patients’ rehabilitation and reduce medical costs. More hospitals and medical systems began to transform to cloud platforms. Some elderly care institutions cooperated with large technology giants such as Microsoft and Google to host their electronic medical records and information systems to provide real-time data insight and more storage solutions.
With the improvement of medical efficiency, EHR for unified management of patient health information will become more and more important. Due to the cost problem of introducing electronic health records, people expect the low-cost cloud EHR system to be popularized as soon as possible.